Other Relevant Articles - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration
Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study
Discharge Against Medical Advice After Percutaneous Coronary Intervention in the United States
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD
Impact of Artificial Intelligence on Interventional Cardiology: From Decision-Making Aid to Advanced Interventional Procedure Assistance
Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database
The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels

Consensus

May 22, 2019

JOURNAL：Circulation.

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk

P Urban, R Mehran, R Colleran et al.

5887

Keywords: high bleeding risk; consensus; EUROPCR 2019

FULL TEXT PDF